Johanna Kaufmann, PhD, discusses promising preclinical findings on first-in-class oncolytic viral therapy in breast cancer treatment.
Johanna Kaufmann, PhD
Advertisement
Articles by Johanna Kaufmann, PhD
Advertisement
Latest Updated Articles
New Pathways for Oncolytic Virals in Breast CancerNovember 9th 2023
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ESMO 2026 Presidential Symposium II Showcases OS-Improving LBAs in Lung and GI Cancers
2
FDA Approves Talazoparib/Enzalutamide in HRR-Mutated Prostate Cancer
3
ESMO 2026: Survival Gains and New Treatment Strategies in GI Cancers
4
ADCs Shine, Mixed Bag for Immunotherapy at ESMO 2026 Presidential Symposium III
5